On September 5, 2022 Phynova Group Ltd reported a new strategic partnership with Singapore-based Nutraconnect Pte, Ltd. to introduce its innovative, scientifically backed nutraceutical ingredient Reducose to critical markets in Asia namely Indonesia & Thailand (Press release, Phynova, SEP 5, 2022, View Source [SID1234618989]). This strategic partnership will also aim to take Reducose to certain Key marquee brands in the APAC region. Reducose turns fast sugars and other carbohydrates into slow ones. It empowers consumers to take back control of their blood sugar fluctuations in response to foods. Reducose is a patented functional ingredient, that is a water extract of white mulberry leaves. It can easily be incorporated into a wide range of foods and drinks or be used in dietary supplements. In several human clinical trials, Reducose has been studied to lower blood glucose after eating foods containing sugars and other carbohydrates. Reducose has also been shown to lower the amount of insulin our bodies need to make, and Reducose will decrease the Glycaemic Index (GI) of common carbohydrates. Blood sugar management is a major health benefit of concern for healthy people who actively seek to manage their energy, concentration, weight and lifestyle. Blood sugar management is also critical for people who live with diabetes or pre-diabetes. Diabetes is now a disease of major concern both globally and in APAC and is a leading cause of death in most countries. In 2021, the International Diabetes Federation (IDF) estimated that ∼537 million people had diabetes worldwide, and by 2030, this is predicted to rise to 643 million. Eighty percent live in low-and middle-income countries, and of the total, more than 60% live in Asia, with almost one-third in China. This strategic partnership combines the strengths of the two companies to bring a natural solution to the consumers who actively seek to live a healthier life through better control of their blood sugar. Stephane Ducroux, CEO at Phynova, said: "We are delighted to have a Strategic Partnership with Nutraconnect. Phynova’s strategy is to partner with market focused experts such as Nutraconnect who have a proven track record of introducing and developing opportunities for ingredients with a strong science like Reducose to certain key marquee brands in the APAC region. "The aim of Nutraconnect is to bring innovative, safe and science backed natural solutions to brand customers in the APAC region. We guide our clients through the regulatory, language, cultural and distribution labyrinth using our experience, reach and knowledge so that we can successfully bring products like Reducose to the market. We are proud of our association with Phynova Group Limited" adds Nikhil Sawant, CEO and Co-founder of Nutraconnect. "To develop formulations that comply to the local regulations, brand customers expect great service and rapid responses, Nutraconnect is based in Asia and in the same time zone as its customers enabling us to meet and exceed the expectations of our customers. The services provided by Nutraconnect is an added competitive advantage for our client to win in the APAC region" adds Rohit Noronha, Chief Growth Officer, and Co-founder of Nutraconnect.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!